Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Plimack, Elizabeth R."'
Autor:
Plimack ER; Fox Chase Cancer Center, Philadelphia, PA, USA. Electronic address: Elizabeth.Plimack@fccc.edu., Powles T; Barts Health NHS Trust and the Royal Free NHS Foundation Trust, Barts Cancer Institute, London, UK; Queen Mary University of London, London, UK., Stus V; Dnipro State Medical University, Dnipro, Dnipropetrovsk Oblast, Ukraine., Gafanov R; Russian Scientific Center of Roentgenology and Radiology, Moscow, Russia., Nosov D; Central Clinical Hospital With Outpatient Clinic, Moscow, Russia., Waddell T; The Christie NHS Foundation Trust, Manchester, UK., Alekseev B; P. A. Herzen Moscow Oncology Research Institute, Ministry of Health of the Russian Federation, Moscow, Russia., Pouliot F; CHU of Québec and Laval University, Québec, QC, Canada., Melichar B; Palacký University Medical School and Teaching Hospital, Olomouc, Czech Republic., Soulières D; Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada., Borchiellini D; Centre Antoine Lacassagne, Université Côte d'Azur, Nice, France., McDermott RS; Adelaide and Meath Hospital, University College Dublin, Belfield, Dublin, Ireland., Vynnychenko I; Sumy Regional Oncology Center, Sumy State University, Sumy, Sumy Oblast, Ukraine., Chang YH; Taipei Veterans General Hospital, Taipei, Taiwan., Tamada S; Bell Land General Hospital, Osaka, Japan., Atkins MB; Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA., Li C; Merck & Co., Inc., Rahway, NJ, USA., Perini R; Merck & Co., Inc., Rahway, NJ, USA., Molife LR; MSD UK, London, UK., Bedke J; University Hospital, Eberhard Karls University Tübingen, Tübingen, Germany., Rini BI; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
Publikováno v:
European urology [Eur Urol] 2024 Feb; Vol. 85 (2), pp. e58-e59. Date of Electronic Publication: 2023 Dec 08.
Autor:
Plimack ER; Fox Chase Cancer Center, Philadelphia, PA, USA. Electronic address: Elizabeth.Plimack@fccc.edu., Powles T; Barts Health NHS Trust and the Royal Free NHS Foundation Trust, Barts Cancer Institute, London, UK; Queen Mary University of London, London, UK., Stus V; Dnipro State Medical University, Dnipro, Dnipropetrovsk Oblast, Ukraine., Gafanov R; Russian Scientific Center of Roentgenology and Radiology, Moscow, Russia., Nosov D; Central Clinical Hospital With Outpatient Clinic, Moscow, Russia., Waddell T; The Christie NHS Foundation Trust, Manchester, UK., Alekseev B; P. A. Herzen Moscow Oncology Research Institute, Ministry of Health of the Russian Federation, Moscow, Russia., Pouliot F; CHU of Québec and Laval University, Québec, QC, Canada., Melichar B; Palacký University Medical School and Teaching Hospital, Olomouc, Czech Republic., Soulières D; Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada., Borchiellini D; Centre Antoine Lacassagne, Université Côte d'Azur, Nice, France., McDermott RS; Adelaide and Meath Hospital, University College Dublin, Belfield, Dublin, Ireland., Vynnychenko I; Sumy Regional Oncology Center, Sumy State University, Sumy, Sumy Oblast, Ukraine., Chang YH; Taipei Veterans General Hospital, Taipei, Taiwan., Tamada S; Bell Land General Hospital, Osaka, Japan., Atkins MB; Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA., Li C; Merck & Co., Inc., Rahway, NJ, USA., Perini R; Merck & Co., Inc., Rahway, NJ, USA., Rhoda Molife L; MSD UK, London, UK., Bedke J; University Hospital, Eberhard Karls University Tübingen, Tübingen, Germany., Rini BI; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
Publikováno v:
European urology [Eur Urol] 2023 Nov; Vol. 84 (5), pp. e123-e124. Date of Electronic Publication: 2023 Sep 02.
Autor:
Plimack ER; Fox Chase Cancer Center, Philadelphia, PA, USA. Electronic address: Elizabeth.Plimack@fccc.edu., Powles T; Barts Health NHS Trust and the Royal Free NHS Foundation Trust, Barts Cancer Institute, London, UK; Queen Mary University of London, London, UK., Stus V; Dnipro State Medical University, Dnipro, Dnipropetrovsk Oblast, Ukraine., Gafanov R; Russian Scientific Center of Roentgenology and Radiology, Moscow, Russia., Nosov D; Central Clinical Hospital With Outpatient Clinic, Moscow, Russia., Waddell T; The Christie NHS Foundation Trust, Manchester, UK., Alekseev B; P. A. Herzen Moscow Oncology Research Institute, Ministry of Health of the Russian Federation, Moscow, Russia., Pouliot F; CHU of Québec and Laval University, Québec, QC, Canada., Melichar B; Palacký University Medical School and Teaching Hospital, Olomouc, Czech Republic., Soulières D; Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada., Borchiellini D; Centre Antoine Lacassagne, Université Côte d'Azur, Nice, France., McDermott RS; Adelaide and Meath Hospital, University College Dublin, Belfield, Dublin, Ireland., Vynnychenko I; Sumy Regional Oncology Center, Sumy State University, Sumy, Sumy Oblast, Ukraine., Chang YH; Taipei Veterans General Hospital, Taipei, Taiwan., Tamada S; Bell Land General Hospital, Osaka, Japan., Atkins MB; Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA., Li C; Merck & Co., Inc., Rahway, NJ, USA., Perini R; Merck & Co., Inc., Rahway, NJ, USA., Molife LR; MSD UK, London, UK., Bedke J; University Hospital, Eberhard Karls University Tübingen, Tübingen, Germany., Rini BI; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
Publikováno v:
European urology [Eur Urol] 2023 Nov; Vol. 84 (5), pp. 449-454. Date of Electronic Publication: 2023 Jul 25.
Autor:
Hahn NM; Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA; The Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD, USA; The James Buchanan Brady Urological Institute, Baltimore, MD, USA. Electronic address: nhahn4@jhmi.edu., O'Donnell MA; University of Iowa Carver College of Medicine, Iowa City, IA, USA., Efstathiou JA; Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Zahurak M; Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA., Rosner GL; Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA., Smith J; Hoosier Cancer Research Network, Indianapolis, IN, USA., Kates MR; Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA; The Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD, USA; The James Buchanan Brady Urological Institute, Baltimore, MD, USA., Bivalacqua TJ; Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA; The Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD, USA; The James Buchanan Brady Urological Institute, Baltimore, MD, USA; Division of Urology and Urologic Surgery, Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Tran PT; Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA; The Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD, USA; The James Buchanan Brady Urological Institute, Baltimore, MD, USA; Department of Radiation Oncology, Johns Hopkins School of Medicine, Baltimore, MD, USA; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, USA., Song DY; Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA; The Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD, USA; The James Buchanan Brady Urological Institute, Baltimore, MD, USA; Department of Radiation Oncology, Johns Hopkins School of Medicine, Baltimore, MD, USA., Baras AS; Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA; The Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD, USA; The James Buchanan Brady Urological Institute, Baltimore, MD, USA; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD, USA., Matoso A; Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA; The Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD, USA; The James Buchanan Brady Urological Institute, Baltimore, MD, USA; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD, USA., Choi W; Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA; The Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD, USA; The James Buchanan Brady Urological Institute, Baltimore, MD, USA., Smith KN; Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA; The Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD, USA; Johns Hopkins Bloomberg Kimmel Institute for Cancer Immunotherapy, Baltimore, MD, USA., Pardoll DM; Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA; The Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD, USA; Johns Hopkins Bloomberg Kimmel Institute for Cancer Immunotherapy, Baltimore, MD, USA., Marchionni L; Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA; The Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD, USA; Johns Hopkins University School of Medicine, Center for Computational Genomics, Baltimore, MD, USA; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA., McGuire B; Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA; The Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD, USA; The James Buchanan Brady Urological Institute, Baltimore, MD, USA., Grace Phelan M; Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA; The Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD, USA; The James Buchanan Brady Urological Institute, Baltimore, MD, USA., Johnson BA 3rd; Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA; The Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD, USA; The James Buchanan Brady Urological Institute, Baltimore, MD, USA., O'Neal T; Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA., McConkey DJ; Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA; The Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD, USA; The James Buchanan Brady Urological Institute, Baltimore, MD, USA., Rose TL; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA; Division of Medical Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC, USA., Bjurlin M; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA; Department of Urology, University of North Carolina, Chapel Hill, NC, USA., Lim EA; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA; Spectrum Health Medical Group, Grand Rapids, MI, USA., Drake CG; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA; Janssen Research and Development, Springhouse, PA, USA., McKiernan JM; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA; Department of Urology, Columbia University, New York, NY, USA., Deutsch I; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA; Department of Radiation Oncology, Columbia University, New York, NY, USA., Anderson CB; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA; Department of Urology, Columbia University, New York, NY, USA., Lamm DL; BCG Oncology, Phoenix, AZ, USA., Geynisman DM; Department of Hematology and Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Plimack ER; Department of Hematology and Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Hallman MA; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Horwitz EM; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Al-Saleem E; Department of Pathology, Fox Chase Cancer Center, Philadelphia, PA, USA., Chen DYT; Department of Urology, Fox Chase Cancer Center, Philadelphia, PA, USA., Greenberg RE; Department of Urology, Fox Chase Cancer Center, Philadelphia, PA, USA., Kutikov A; Department of Urology, Fox Chase Cancer Center, Philadelphia, PA, USA., Guo G; Department of Radiation Oncology, Indiana University Simon Cancer Center, Indianapolis, IN, USA; University Hospitals Cleveland Medical Center, Cleveland, OH, USA., Masterson TA; Department of Urology, Indiana University Simon Cancer Center, Indianapolis, IN, USA., Adra N; Division of Hematology and Oncology, Indiana University Simon Cancer Center, Indianapolis, IN, USA., Kaimakliotis HZ; Department of Urology, Indiana University Simon Cancer Center, Indianapolis, IN, USA.
Publikováno v:
European urology [Eur Urol] 2023 Jun; Vol. 83 (6), pp. 486-494. Date of Electronic Publication: 2023 Jan 28.
Autor:
Ghatalia P; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA. Electronic address: pooja.ghatalia@fccc.edu., Plimack ER; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.
Publikováno v:
European urology [Eur Urol] 2022 Nov; Vol. 82 (5), pp. 527-528. Date of Electronic Publication: 2022 Sep 02.
Autor:
Bedke J; Department of Urology, Eberhard Karls University of Tübingen, Tübingen, Germany. Electronic address: jens.bedke@med.uni-tuebingen.de., Rini BI; Vanderbilt University Medical Center, Nashville, TN, USA., Plimack ER; Fox Chase Cancer Center, Philadelphia, PA, USA., Stus V; Dnipro State Medical University, Dnipro, Ukraine., Gafanov R; Russian Scientific Center of Roentgen Radiology, Moscow, Russia., Waddell T; The Christie NHS Foundation Trust, Manchester, UK., Nosov D; Central Clinical Hospital With Outpatient Clinic, Moscow, Russia., Pouliot F; CHU de Québec and Université Laval, Quebec City, QC, Canada., Soulières D; Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada., Melichar B; Palacký University Olomouc, Medical School and Teaching Hospital, Olomouc, Czech Republic., Vynnychenko I; Sumy State University, Sumy Regional Oncology Center, Sumy, Ukraine., Azevedo SJ; Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil., Borchiellini D; Centre Antoine Lacassagne, Université Côte d'Azur, Nice, France., McDermott RS; Adelaide and Meath Hospital, University College Dublin, Dublin, Ireland., Tamada S; Bell Land General Hospital, Osaka, Japan., Nguyen AM; Merck & Co., Inc., Rahway, NJ, USA., Wan S; Merck & Co., Inc., Rahway, NJ, USA., Perini RF; Merck & Co., Inc., Rahway, NJ, USA., Rhoda Molife L; MSD UK, London, UK., Atkins MB; Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA., Powles T; Barts Health and the Royal Free NHS Trusts, Barts Cancer Institute, London, UK; Queen Mary University of London, London, UK.
Publikováno v:
European urology [Eur Urol] 2022 Oct; Vol. 82 (4), pp. 427-439. Date of Electronic Publication: 2022 Jul 15.
Autor:
Reig Torras O; Kidney Cancer Program, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX, USA; Translational Genomic and Targeted Therapeutics in Solid Tumors, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain; Department of Medical Oncology, Hospital Clínic of Barcelona, Barcelona, Spain., Mishra A; Kidney Cancer Program, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX, USA., Christie A; Kidney Cancer Program, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX, USA; Division of Biostatistics, Department of Clinical Sciences, The University of Texas Southwestern Medical Center, Dallas, TX, USA., McKenzie T; Kidney Cancer Program, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Pathology, The University of Texas Southwestern Medical Center, Dallas, TX, USA., Onabolu O; Kidney Cancer Program, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX, USA., Singla N; Kidney Cancer Program, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Urology, The University of Texas Southwestern Medical Center, Dallas, TX, USA., Plimack ER; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Suárez C; Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain., Ornstein MC; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA., Alpaugh RK; Protocol Support Laboratory, Fox Chase Cancer Center, Philadelphia, PA, USA., Elias R; Kidney Cancer Program, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX, USA., Bowman IA; Kidney Cancer Program, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX, USA., McKay RM; Kidney Cancer Program, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX, USA., Przybycin C; Robert J. Tomsich Institute of Pathology and Laboratory Medicine, Department of Pathology, Cleveland Clinic, Cleveland, OH, USA., Kapur P; Kidney Cancer Program, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Pathology, The University of Texas Southwestern Medical Center, Dallas, TX, USA., Brugarolas J; Kidney Cancer Program, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX, USA. Electronic address: james.brugarolas@utsw.edu., Rini B; Department of Hematology and Medical Oncology, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: brian.rini@vumc.org.
Publikováno v:
European urology [Eur Urol] 2022 Jun; Vol. 81 (6), pp. 555-558. Date of Electronic Publication: 2021 Dec 31.
Autor:
Albiges L; Department of Cancer Medicine, Gustave Roussy, Villejuif, France. Electronic address: laurence.albiges@gustaveroussy.fr., Tannir NM; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Burotto M; Bradford Hill Clinical Research Center, Santiago, Chile., McDermott D; Division of Medical Oncology, Beth Israel Deaconess Medical Center, Dana-Farber/Harvard Cancer Center, Boston, MA, USA., Plimack ER; Department of Hematology and Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Barthélémy P; Medical Oncology, Institut de Cancérologie Strasbourg Europe, Strasbourg, France., Porta C; University of Pavia, Pavia, Italy., Powles T; Department of Urology, Barts Cancer Institute, Queen Mary University of London, Royal Free NHS Trust, London, UK., Donskov F; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., George S; Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA., Kollmannsberger CK; Department of Medicine, British Columbia Cancer Agency, Vancouver, Canada., Gurney H; Department of Medical Oncology, Westmead Hospital and Macquarie University, Sydney, Australia., Grimm MO; Department of Urology, Jena University Hospital, Jena, Germany., Tomita Y; Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan., Castellano D; Medical Oncology Service, Hospital Universitario 12 de Octubre, Madrid, Spain., Rini BI; Division of Hematology Oncology, Vanderbilt University Medical Center, Nashville, TN, USA., Choueiri TK; Department of Medical Oncology, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Leung D; Department of Imaging, Bristol Myers Squibb, Princeton, NJ, USA., Saggi SS; Department of Clinical Trials, Bristol Myers Squibb, Princeton, NJ, USA., Lee CW; Department of Clinical Trials, Bristol Myers Squibb, Princeton, NJ, USA., McHenry MB; Department of Biostatistics, Bristol Myers Squibb, Princeton, NJ, USA., Motzer RJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Publikováno v:
European urology [Eur Urol] 2022 Mar; Vol. 81 (3), pp. 266-271. Date of Electronic Publication: 2021 Nov 05.
Autor:
Miron B; Fox Chase Cancer Center, Philadelphia, PA, USA., Bukavina L; Fox Chase Cancer Center, Philadelphia, PA, USA., Plimack ER; Fox Chase Cancer Center, Philadelphia, PA, USA. Electronic address: elizabeth.plimack@fccc.edu.
Publikováno v:
European urology [Eur Urol] 2022 Jan; Vol. 81 (1), pp. 62-63. Date of Electronic Publication: 2021 Nov 05.
Autor:
Geynisman DM; Hematology/Oncology, Fox Chase Cancer Center, Temple Health, Philadelphia, PA, USA., Plimack ER; Hematology/Oncology, Fox Chase Cancer Center, Temple Health, Philadelphia, PA, USA. Electronic address: elizabeth.plimack@fccc.edu.
Publikováno v:
European urology [Eur Urol] 2021 Aug; Vol. 80 (2), pp. 171-173. Date of Electronic Publication: 2021 May 07.